Cargando…
ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib
Despite the high efficacy of imatinib mesylate (IM) treatment for chronic myeloid leukemia (CML) patients, some individuals develop resistance due to impaired bioavailability. It has been previously demonstrated that the haplotypes for ATP-binding cassette subfamily B member 1 (ABCB1)with c.1236C>...
Autores principales: | VIVONA, DOUGLAS, LIMA, LUCIENE TEREZINA, RODRIGUES, ALICE CRISTINA, BUENO, CAROLINA TOSIN, ALCANTARA, GREYCE KELLY STEINHORST, BARROS, LUIZA SALDANHA RIBEIRO, DE MORAES HUNGRIA, VANIA TIESTSCHE, CHIATTONE, CARLOS SÉRGIO, DE LOURDES LOPES FERRARI CHAUFFAILLE, MARIA, GUERRA-SHINOHARA, ELVIRA MARIA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961201/ https://www.ncbi.nlm.nih.gov/pubmed/24660038 http://dx.doi.org/10.3892/ol.2014.1857 |
Ejemplares similares
-
SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia
por: Singh, Onkar, et al.
Publicado: (2012) -
ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro
por: Skoglund, Karin, et al.
Publicado: (2013) -
Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes
por: Venuto, Rocco C., et al.
Publicado: (2015) -
Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice
por: Gardner, Erin R, et al.
Publicado: (2009) -
For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission
por: Silva, Luiza Soares Vieira da, et al.
Publicado: (2017)